Skip to main content

Day: February 7, 2020

MT Højgaard Holding A/S: Major shareholder announcement

Pursuant to section 30 of the Danish capital markets act, MT Højgaard Holding A/S hereby announces that Investeringsforeningen Nordea Invest has reported to have reduced its holding of shares in MT Højgaard Holding A/S to 378,762 shares, corresponding to 4.86% of the share capital.Control with the associated voting rights has been transferred by proxy to Nordea Funds Ltd., which now controls 7.41% of the total voting rights.Contact: VP Communications and HR Ann-Louise Elkjær, +45 2033 8693, ale@mth.dkAttachmentNo_5_2020_Major shareholder announcement_7Feb2020

Continue reading

MT Højgaard Holding A/S: Storaktionærmeddelelse

MT Højgaard Holding A/S oplyser i medfør af § 30 i lov om kapitalmarkeder, at Investeringsforeningen Nordea Invest har meddelt at have reduceret sin beholdning i MT Højgaard Holding A/S til 378.762 aktier svarende til 4,86% af aktiekapitalen.Kontrollen over de tilhørende stemmerettigheder er ved fuldmagt overdraget til Nordea Funds Ltd., som herefter råder over 7,41% af de samlede stemmerettigheder.Kontakt: Kommunikations- og HR-direktør Ann-Louise Elkjær, +45 2033 8693, ale@mth.dkVedhæftet filNr_5_2020_Storaktionærmeddelelse_7feb2020

Continue reading

Catalyst Biosciences Presents Positive Data from its Phase 2b Trial of Subcutaneous Dalcinonacog Alfa (DalcA) and Marzeptacog alfa (activated) (MarzAA) Programs at the 13th Annual EAHAD Congress

Enrollment in the DalcA trial is complete; results demonstrate DalcA provides Factor IX (FIX) activity exceeding the efficacy endpoint with no anti-drug antibodiesCompany to host investor call and webcast on Friday, February 7 at 8:30 a.m. ETSOUTH SAN FRANCISCO, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — Catalyst Biosciences, Inc. (NASDAQ: CBIO), today announced positive efficacy and safety data from its Phase 2b trial of DalcA, a next-generation subcutaneously (SQ) administered Factor IX (FIX) therapy being developed for the treatment of hemophilia B. The data were presented by Johnny Mahlangu, M.B.B.Ch., M.Med, F.C.Path, professor of haematology, faculty of health sciences, head of the School of Pathology at the University of Witwatersrand in Johannesburg, South Africa, and principal investigator in the clinical trial in an oral...

Continue reading

Deficit for Swedish central government in January 2020

Swedish central government payments resulted in a deficit of SEK 3.0 billion in January. The Debt Office’s forecast was a deficit of SEK 2.3 billion. A lower primary balance than expected was offset by lower net lending to government agencies.The primary balance, the difference between central government income and expenditure, was 3.9 billion lower than expected. Tax income was approximately SEK 1 billion lower than forecasted. In addition, the disbursements by some government agencies such as the Swedish International Cooperation Agency and the Swedish Armed Forces were slightly higher than expected in January.The Debt Office’s net lending to government agencies etc. was SEK 3.2 billion lower than expected. This was mainly due to lower lending to the Swedish Board of Student Finance and higher deposits, from among others,...

Continue reading

Underskott för staten i januari 2020

Statens betalningar resulterade i ett underskott på 3,0 miljarder kronor i januari. Riksgäldens prognos var ett underskott på 2,3 miljarder kronor. Ett lägre primärt saldo än prognos motverkades av lägre nettoutlåning till myndigheter.Det primära saldot, som består av skillnaden mellan statens inkomster och utgifter, blev 3,9 miljarder kronor lägre än i prognos. Skatteinkomsterna var cirka 1 miljard kronor lägre än beräknat. Samtidigt blev myndigheternas utgifter något högre, bland annat på grund av högre utgifter för SIDA och Försvarsmakten.Riksgäldens nettoutlåning till myndigheter m.fl. var 3,2 miljarder kronor lägre än beräknat. Det berodde främst på lägre utlåning till CSN...

Continue reading

Kommende ændringer i bestyrelsen i Djurslands Bank A/S

Fondsbørsmeddelelse 4/2020På bankens kommende generalforsamling onsdag den 11. marts 2020 i Grenaa Idrætscenter fratræder bankens nuværende bestyrelsesmedlem Peter Pedersen.Evt. spørgsmål hertil kan rettes til bankdirektør Lars Møller Kristensen.Venlig hilsenDjurslands Bank     Vedhæftet fil04-2020 Fondsbørsmeddelelse 07.02.2020

Continue reading

SMART Global Holdings Announces Pricing of Upsized Private Offering of $220 Million Convertible Notes

NEWARK, Calif., Feb. 07, 2020 (GLOBE NEWSWIRE) — SMART Global Holdings, Inc. (“SMART” or the “Company”) (Nasdaq: SGH), parent company of SMART Modular Technologies, Inc., today announced the pricing of $220 million in aggregate principal amount of convertible senior notes due 2026 (the “Notes”) to be offered and sold to qualified institutional buyers as defined in Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of the offering was increased from the previously announced offering size of $200 million. The Company has granted the initial purchasers an option to purchase up to an additional $30 million principal amount of Notes. The offering is expected to close on or about February 11, 2020, subject to customary closing conditions.SMART...

Continue reading

StrongPoint ASA: Presentation of 4th quarter 2019 results followed by a company strategy update session

(Oslo, Norway 7 February 2020) StrongPoint ASA (StrongPoint, OSE: STRONG)StrongPoint ASA will publish its financial results for the fourth quarter 2019 on Wednesday 12 February 2020. The presentation of the fourth quarter 2019 financial results followed by an extended company strategy update session will take place at ABG Sundal Collier, Munkedamsveien 45 E, 7th floor, 0250 Oslo at 08:15 am CET.The financial results for the fourth quarter 2019 and the presentation for the strategy update session will be announced at 07:00 CET through the Oslo Stock Exchange distribution service and also made available on www.strongpoint.com. The Q4 2019 financial results presentation and the company strategy update session will be streamed lived at: https://channel.royalcast.com/webcast/hegnarmedia/20200212_6/Registration: Please send an email to...

Continue reading

Hofseth Biocare ASA: Fourth Quarter 2019 Financial Report

Hofseth BioCare ASA (“HBC”) had operating revenues of NOK 11.1m (NOK 14.5m) in the fourth quarter of 2019. Cost of Goods Sold (CoGS) amounted to NOK 8.4m (NOK 9.9m) in the period. Operational profit (EBITDA) for the fourth quarter 2019 was negative NOK 15.0m (NOK 13.1m). Net financial items in the fourth quarter were negative NOK 2.6m (negative NOK 4.6m). Loss before tax was NOK 25.6m in the quarter, compared to a loss of NOK 23.5m during fourth quarter 2018.Cash flow from operations during the fourth quarter was negative NOK 10.8m compared to positive NOK 46.2m in the same quarter last year. Cash and cash equivalents decreased by NOK 14.8m during the quarter, leaving total holding of cash and cash equivalents at NOK 94.6m by the end of the period.Total assets for HBC were NOK 302.7m at the end of fourth quarter of 2019...

Continue reading

Halvårsrapport 2019/2020 for perioden 01.07.2019 – 31.12.2019

MÅ IKKE OFFENTLIGGØRES, DISTRIBUERES ELLER UDLEVERES HELT ELLER DELVIST, DIREKTE ELLER INDIREKTE, I ELLER TIL USA, AUSTRALIEN, CANADA ELLER JAPAN.Selskabsmeddelelse nr. 18-2020Odense, 7. februar 2020Halvårsrapport 2019/2020 for perioden 01.07.2019 – 31.12.2019Koncernens hovedaktiviteterKoncernen består af moderselskabet Odico A/S samt datterselskaberne Odico Formworks ApS og Ejendomsselskabet Oslogade 1, Odense ApS.Koncernens- og moderselskabets hovedaktivitet omfatter udvikling, fremstilling og afsætning af avancerede robotteknologiske løsninger til bl.a. byggeindustrien. Teknologiplatformen – et koncept kaldet ’Factory On The Fly’ – baserer sig på standard industrirobotter i sammenhæng med egenudviklet software, skæreværktøjer og...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.